1. Home
  2. MRSN vs SOTK Comparison

MRSN vs SOTK Comparison

Compare MRSN & SOTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • SOTK
  • Stock Information
  • Founded
  • MRSN 2001
  • SOTK 1975
  • Country
  • MRSN United States
  • SOTK United States
  • Employees
  • MRSN N/A
  • SOTK N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • SOTK Industrial Machinery/Components
  • Sector
  • MRSN Health Care
  • SOTK Technology
  • Exchange
  • MRSN Nasdaq
  • SOTK Nasdaq
  • Market Cap
  • MRSN 47.1M
  • SOTK 52.1M
  • IPO Year
  • MRSN 2017
  • SOTK 1987
  • Fundamental
  • Price
  • MRSN $27.87
  • SOTK $4.40
  • Analyst Decision
  • MRSN Buy
  • SOTK Hold
  • Analyst Count
  • MRSN 5
  • SOTK 1
  • Target Price
  • MRSN $30.38
  • SOTK N/A
  • AVG Volume (30 Days)
  • MRSN 211.4K
  • SOTK 44.3K
  • Earning Date
  • MRSN 11-14-2025
  • SOTK 10-14-2025
  • Dividend Yield
  • MRSN N/A
  • SOTK N/A
  • EPS Growth
  • MRSN N/A
  • SOTK 6.63
  • EPS
  • MRSN N/A
  • SOTK 0.10
  • Revenue
  • MRSN $33,180,000.00
  • SOTK $20,607,030.00
  • Revenue This Year
  • MRSN N/A
  • SOTK $2.67
  • Revenue Next Year
  • MRSN N/A
  • SOTK $8.20
  • P/E Ratio
  • MRSN N/A
  • SOTK $44.70
  • Revenue Growth
  • MRSN N/A
  • SOTK N/A
  • 52 Week Low
  • MRSN $5.21
  • SOTK $3.23
  • 52 Week High
  • MRSN $70.73
  • SOTK $6.05
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 89.87
  • SOTK 43.24
  • Support Level
  • MRSN $7.59
  • SOTK $4.30
  • Resistance Level
  • MRSN $28.07
  • SOTK $4.55
  • Average True Range (ATR)
  • MRSN 0.69
  • SOTK 0.26
  • MACD
  • MRSN 1.80
  • SOTK -0.05
  • Stochastic Oscillator
  • MRSN 99.51
  • SOTK 0.00

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About SOTK Sono-Tek Corporation

Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

Share on Social Networks: